Polar Capital Holdings plc (POLR)
London Exchange · UK · prices in GBX · close of 19 Oct 2026
Key indicators
| Last close | GBX 750.00 |
|---|---|
| 52-week range | 477.56 – 955.49 |
| Return, 1 month / 3 months | −10.2% / −13.8% |
| Return, 1 year / 3 years | +47.7% / +141.1% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 33 |
| Volatility (1 year) | 34.3% |
| Worst drawdown (1 year) | -20.6% |
| Average daily value traded | 312.70M GBX |
| Dividend yield | 0.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Polar Capital Holdings is an investment management firm based in London. It runs specialist funds that focus on particular sectors, including technology, healthcare, financials and emerging markets, and it also manages funds for clients seeking exposure to these areas. Its customers are mainly institutional investors, professional advisers and other professional clients who invest through the funds it manages. The company earns its income from the management fees charged on the assets held in those funds.
On this site Polar Capital Holdings plc appears as a stock on the London Exchange (UK), code POLR, with prices in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Polar Capital Holdings plc (POLR) trades on the London Exchange in UK. It last closed at GBX 750.00 on 19 October 2026.
Its price-based Market X-Ray is 66 out of 100 (a fair price profile), ranking 876 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 47.7% and over the last three months it fell 13.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 62 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 1.9% | ||
| From 52-week high | -20.6% | ||
| Momentum | 61 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -13.8% | ||
| 6-month return | 11.3% | ||
| 12-month return, skipping the last month | 64.5% | ||
| Stability (higher is calmer) | 61 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 34.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -20.6% | ||
| Liquidity | 94 · Strong | Trades actively. | |
| Average daily value traded | 312.70M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 56 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 0.1% | ||
| Years with dividends | 6 |
Strengths
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −5.3% |
|---|---|
| 1 month | −10.2% |
| 3 months | −13.8% |
| 6 months | +11.3% |
| 1 year | +47.7% |
| 3 years | +141.1% |
| 5 years | +38.3% |
Signals
| 50-day / 200-day average | 837.46 / 736.34 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 34.44 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 9 Jul 2026 | GBP 0.3200 |
| 11 Dec 2025 | GBP 0.1400 |
| 10 Jul 2025 | GBP 0.3200 |
| 12 Dec 2024 | GBP 0.1400 |
| 4 Jul 2024 | GBP 0.3200 |
| 14 Dec 2023 | GBP 0.1400 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.